All Stories

  1. Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using deep docking
  2. Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau
  3. Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
  4. Rapid elongation drives the exceptionally fast aggregation of medin, the most common localized human amyloid
  5. Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model
  6. Classification of Tauopathies from Human Brain Homogenates through Salt-Modulated Tau Amplification
  7. Recruitment of Aβ into α-Synuclein Condensates Catalyzes Primary Nucleation of α-Synuclein Aggregation
  8. Sequence-based virtual screening using transformers
  9. Aβ42 promotes the aggregation of α‐synuclein splice isoforms via heterogeneous nucleation
  10. Amyloid-β modulates the phase separation and aggregation of α-synuclein
  11. Targeted Protein Modification with an Antibody-Based System
  12. Proteostasis signatures in human diseases
  13. The thermodynamic hypothesis of protein aggregation
  14. Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core
  15. Prediction of Antibody Non-Specificity using Protein Language Models and Biophysical Parameters
  16. Aggregation of α-synuclein splice isoforms through a phase separation pathway
  17. Linking Aβ and tau in the amyloid cascade through the intersection of their proteostasis networks
  18. Serial amplification of tau filaments using Alzheimer’s brain homogenates and C322A or C322S recombinant tau
  19. Natural aminosterols inhibit NMDA receptors with low nanomolar potency
  20. The α-Synuclein Proteostasis Network and its Translational Applications in Parkinson’s disease
  21. Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay
  22. Detection of protein oligomers with nanopores 
  23. AlphaFold prediction of structural ensembles of disordered proteins
  24. Design of Protein Sequences with Precisely Tuned Kinetic Properties
  25. Lipid-induced condensate formation from the Alzheimer’s Aβ peptide triggers amyloid aggregation
  26. Sustainable and Surfactant-Free Synthesis of Negatively Charged Acrylamide Nanogels for Biomedical Applications
  27. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  28. Structural commonalities determined by physicochemical principles in the complex polymorphism of the amyloid state of proteins
  29. Estimation of Ligand Binding Free Energy Using Multi-eGO
  30. Proteostasis Signatures in Human Diseases
  31. Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients
  32. Estimation of ligand binding free energy using multi-eGO.
  33. Language Models for Molecular Dynamics
  34. A scale-invariant log-normal droplet size distribution below the critical concentration for protein phase separation
  35. A scale-invariant log-normal droplet size distribution below the critical concentration for protein phase separation
  36. Organization of the Proteostasis Network of Membraneless Organelles
  37. AlphaFold-Metainference: Prediction of Structural Ensembles of Disordered Proteins
  38. Global kinetic model of lipid-inducedα-synuclein aggregation and its inhibition by small molecules
  39. A rapid in vivo pipeline to identify small molecule inhibitors of amyloid aggregation
  40. TNF⍺-driven Aβ aggregation, synaptic dysfunction and hypermetabolism in human iPSC-derived cortical neurons
  41. AlphaFold2-based prediction of the co-condensation propensity of proteins
  42. Estimation of ligand binding free energy using multi-eGO.
  43. Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers
  44. Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery
  45. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A
  46. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A
  47. Identification of high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking
  48. Pharmacological inhibition of α-synuclein aggregation within liquid condensates
  49. Targeted protein editing with an antibody-based system
  50. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms
  51. Maturation-dependent changes in the size, structure and seeding capacity of Aβ42 amyloid fibrils
  52. Sequence-Based Drug Design Using Transformers
  53. Imaging Aβ aggregation by liquid-phase transmission electron microscopy
  54. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  55. Using Generative Modeling to Endow with Potency Initially Inert Compounds with Good Bioavailability and Low Toxicity
  56. Transient interactions between the fuzzy coat and the cross-β core of brain-derived Aβ42 filaments
  57. Aggregation of the Amyloid-β Peptide (Aβ40) within Condensates Generated through Liquid-Liquid Phase Separation
  58. Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
  59. Bayesian Optimization in the Latent Space of a Variational Autoencoder for the Generation of Selective FLT3 Inhibitors
  60. CryoENsemble - a Bayesian approach for reweighting biomolecular structural ensembles using heterogeneous cryo-EM maps
  61. Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation
  62. Pharmacological inhibition of α-synuclein aggregation within liquid condensates
  63. Secondary Processes Dominate the Quiescent, Spontaneous Aggregation of α-Synuclein at Physiological pH with Sodium Salts
  64. Targeted protein modification with an antibody-based system
  65. Determination of the Structure and Dynamics of the Fuzzy Coat of an Amyloid Fibril of IAPP Using Cryo-Electron Microscopy
  66. Amyloid formation as a protein phase transition
  67. Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation
  68. Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains
  69. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases
  70. FuzPred: a web server for the sequence-based prediction of the context-dependent binding modes of proteins
  71. Exploration and Exploitation Approaches Based on Generative Machine Learning to Identify Potent Small Molecule Inhibitors of α-Synuclein Secondary Nucleation
  72. AlphaFold Prediction of Structural Ensembles of Disordered Proteins
  73. Extracellular protein homeostasis in neurodegenerative diseases
  74. Spontaneous nucleation and fast aggregate-dependent proliferation of α-synuclein aggregates within liquid condensates at neutral pH
  75. Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
  76. Sequence-based prediction of pH-dependent protein solubility using CamSol
  77. AlphaFold Prediction of Structural Ensembles of Disordered Proteins
  78. Enhanced surface nanoanalytics of transient biomolecular processes
  79. Fragment-based computational design of antibodies targeting structured epitopes
  80. Sequence-based Prediction of the Cellular Toxicity Associated with Amyloid Aggregation within Protein Condensates
  81. Protein condensation diseases: therapeutic opportunities
  82. ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy
  83. Adsorption free energy predicts amyloid protein nucleation rates
  84. π-Clamp-Mediated Homo- and Heterodimerization of Single-Domain Antibodies via Site-Specific Homobifunctional Conjugation
  85. Are casein micelles extracellular condensates formed by liquid‐liquid phase separation?
  86. A Small Molecule Stabilizes the Disordered Native State of the Alzheimer’s Aβ Peptide
  87. Determination of the structure and dynamics of the fuzzy coat of an amyloid fibril of IAPP using cryo-electron microscopy
  88. FuzDrop on AlphaFold: visualizing the sequence-dependent propensity of liquid–liquid phase separation and aggregation of proteins
  89. Conformational Entropy as a Potential Liability of Computationally Designed Antibodies
  90. Kinetic profiling of therapeutic strategies for inhibiting the formation of amyloid oligomers
  91. A Machine Learning Approach to Identify Small Molecule Inhibitors of Secondary Nucleation in α-Synuclein Aggregation
  92. Sequence Determinants of the Aggregation of Proteins Within Condensates Generated by Liquid-liquid Phase Separation
  93. Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
  94. Common sequence motifs of nascent chains engage the ribosome surface and trigger factor
  95. Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
  96. Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation
  97. A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms
  98. A small molecule stabilises the disordered native state of the Alzheimer’s Aβ peptide
  99. Vitamin A and vitamin E metabolites comodulate amyloid-β aggregation
  100. The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
  101. The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances Aβ42 aggregation
  102. A maximum caliber approach for continuum path ensembles
  103. The Amyloid-β Pathway in Alzheimer’s Disease
  104. Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine
  105. Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  106. Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
  107. Generic nature of the condensed states of proteins
  108. A mistranslation-prone transcriptome underlying polyglutamine expansion diseases
  109. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans
  110. A structural ensemble of a tau-microtubule complex reveals regulatory tau phosphorylation and acetylation mechanisms
  111. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases
  112. The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
  113. Aβ Oligomers Dysregulate Calcium Homeostasis by Mechanosensitive Activation of AMPA and NMDA Receptors
  114. Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers
  115. Facile Installation of Post-translational Modifications on the Tau Protein via Chemical Mutagenesis
  116. A kinetic ensemble of the Alzheimer’s Aβ peptide
  117. Computational maturation of a single-domain antibody against Aβ42 aggregation
  118. Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy
  119. A method of incorporating rate constants as kinetic constraints in molecular dynamics simulations
  120. Environmental Dependence of the Structure of the C-terminal Domain of the SARS-CoV-2 Envelope Protein
  121. Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
  122. Widespread occurrence of the droplet state of proteins in the human proteome
  123. Sequence determinants of the aggregation of proteins within condensates generated by liquid-liquid phase separation
  124. Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
  125. A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms
  126. An intrinsically disordered motif regulates the interaction between the p47 adaptor and the p97 AAA+ ATPase
  127. Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
  128. Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
  129. Kinetic analysis reveals the rates and mechanisms of protein aggregation in a multicellular organism
  130. Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
  131. Single molecule secondary structure determination of proteins through infrared absorption nanospectroscopy
  132. Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
  133. Sequence-based prediction of protein binding mode landscapes
  134. Assessing motor-related phenotypes of Caenorhabditis elegans with the wide field-of-view nematode tracking platform
  135. A kinetic ensemble of the Alzheimer’s Aβ peptide
  136. Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  137. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  138. Complexity in Lipid Membrane Composition Induces Resilience to Aβ42 Aggregation
  139. Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
  140. Chris Dobson (1949–2019)
  141. Widespread remodeling of proteome solubility in response to different protein homeostasis stresses
  142. The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State
  143. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
  144. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
  145. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM
  146. Proteome-wide observation of the phenomenon of life on the edge of solubility
  147. Determination of a Structural Ensemble Representing the Dynamics of a G-Quadruplex DNA
  148. Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons
  149. Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation
  150. Probing the dynamic stalk region of the ribosome using solution NMR
  151. Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers
  152. Determination of protein structural ensembles using cryo-electron microscopy
  153. Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response
  154. Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies
  155. Identifying A- and P-site locations on ribosome-protected mRNA fragments using Integer Programming
  156. The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
  157. Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
  158. A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli
  159. Atomic force microscopy for single molecule characterisation of protein aggregation
  160. A superposition free method for protein conformational ensemble analyses and local clustering based on a differential geometry representation of backbone
  161. Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
  162. Effects of α-tubulin acetylation on microtubule structure and stability
  163. Chemical and mechanistic analysis of photodynamic inhibition of Alzheimer's β-amyloid aggregation
  164. Bayesian Weighing of Electron Cryo-Microscopy Data for Integrative Structural Modeling
  165. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology
  166. Identifying A- and P-site locations on ribosome-protected mRNA fragments using Integer Programming
  167. In vitro and in silico assessment of the developability of a designed monoclonal antibody library
  168. Determination of Structural Ensembles of Proteins: Restraining vs Reweighting
  169. Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
  170. SAR by kinetics for drug discovery in protein misfolding diseases
  171. Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
  172. Intrinsically aggregation-prone proteins form amyloid-like aggregates and contribute to tissue aging in C. elegans
  173. Fast fluorescence lifetime imaging reveals the aggregation processes of α-synuclein and polyglutamine in aging Caenorhabditis elegans
  174. Systematic mapping of free energy landscapes of a growing filamin domain during biosynthesis
  175. Stabilization and Characterization of Cytotoxic Aβ40 Oligomers Isolated from an Aggregation Reaction in the Presence of Zinc Ions
  176. Author Correction: The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
  177. Structural Ensemble Modulation upon Small-Molecule Binding to Disordered Proteins
  178. Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery
  179. Molecular dynamics ensemble refinement of the heterogeneous native state of NCBD using chemical shifts and NOEs
  180. Determination of the conformational states of strychnine using NMR residual dipolar couplings in a tensor-free approach
  181. Exploring the role of post-translational modifications in regulating α-synuclein interactions by studying the effects of phosphorylation on nanobody binding
  182. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
  183. Reversible inhibition of the ClpP protease via an N-terminal conformational switch
  184. Cooperative Assembly of Hsp70 Subdomain Clusters
  185. A method for partitioning the information contained in a protein sequence between its structure and function
  186. A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet β-Cells
  187. Developing NMR methods for macromolecular machines: Measurement of residual dipolar couplings to probe dynamical regions of the ribosome
  188. Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
  189. Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation
  190. Parapred: antibody paratope prediction using convolutional and recurrent neural networks
  191. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions
  192. Simultaneous Determination of Protein Structure and Dynamics Using Cryo-Electron Microscopy
  193. Molecular determinants of the interaction of EGCG with ordered and disordered proteins
  194. Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide
  195. Molecular dynamics ensemble refinement of the heterogeneous native state of NCBD using chemical shifts and NOEs
  196. Third generation antibody discovery methods:in silicorational design
  197. Structural differences between toxic and nontoxic HypF-N oligomers
  198. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
  199. Simultaneous Determination of Protein Structure and Dynamics Using Cryo-Electron Microscopy
  200. MobiDB 3.0: more annotations for intrinsic disorder, conformational diversity and interactions in proteins
  201. Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles
  202. Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo
  203. In Vitro and In Silico Activity of Iridoids Against Leishmania ama-zonensis
  204. Influence of Harvest Season and Cultivar on the Variation of Phenolic Compounds Composition and Antioxidant Properties in Vaccinium ashei Leaves
  205. Systematic mapping of the free energy landscapes of a growing immunoglobulin domain identifies a kinetic intermediate associated with co-translational proline isomerization
  206. Paratope Prediction using Convolutional and Recurrent Neural Networks
  207. Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered Peptide
  208. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
  209. Rapid and accurate in silico solubility screening of a monoclonal antibody library
  210. Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
  211. Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species
  212. Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease
  213. Methods of probing the interactions between small molecules and disordered proteins
  214. Amyloid-like Fibrils from an α-Helical Transmembrane Protein
  215. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
  216. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
  217. Corrigendum: Structural basis of synaptic vesicle assembly promoted by α-synuclein
  218. Structural Characterization of the Early Events in the Nucleation–Condensation Mechanism in a Protein Folding Process
  219. The RNF168 paralog RNF169 defines a new class of ubiquitylated histone reader involved in the response to DNA damage
  220. Emergence and evolution of an interaction between intrinsically disordered proteins
  221. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS
  222. MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions
  223. Simultaneous quantification of protein order and disorder
  224. Bayesian weighing of electron cryo-microscopy data for integrative structural modeling
  225. Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation
  226. Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species
  227. Widespread Proteome Remodeling and Aggregation in Aging C. elegans
  228. Networks of Dynamic Allostery Regulate Enzyme Function
  229. Principles of protein structural ensemble determination
  230. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
  231. Scaling behaviour and rate-determining steps in filamentous self-assembly
  232. Simultaneous NMR characterisation of multiple minima in the free energy landscape of an RNA UUCG tetraloop
  233. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
  234. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
  235. Simultaneous Production of Amyloglucosidase and Exo-Polygalacturonase by Aspergillus niger in a Rotating Drum Reactor
  236. Structural basis of synaptic vesicle assembly promoted by α-synuclein
  237. Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation
  238. Metadynamic metainference: Enhanced sampling of the metainference ensemble using metadynamics
  239. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimers disease
  240. Towards a structural biology of the hydrophobic effect in protein folding
  241. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
  242. Structure of a low-population binding intermediate in protein-RNA recognition
  243. Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity
  244. Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein
  245. Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability
  246. Structural characterization of the interaction of α-synuclein nascent chains with the ribosomal surface and trigger factor
  247. A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation
  248. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
  249. Identification and Structural Characterization of an Intermediate in the Folding of the Measles Virus X Domain
  250. A structural ensemble of a ribosome–nascent chain complex during cotranslational protein folding
  251. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins
  252. Molecular Recognition by Templated Folding of an Intrinsically Disordered Protein
  253. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A 42 aggregates linked with Alzheimers disease
  254. Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution Conditions
  255. Metainference: A Bayesian inference method for heterogeneous systems
  256. Hamiltonian Dynamics of Protein Filament Formation
  257. Molecular mechanisms of protein aggregation from global fitting of kinetic models
  258. Particle-Based Monte-Carlo Simulations of Steady-State Mass Transport at Intermediate Péclet Numbers
  259. Structural Insights into the Calcium-Mediated Allosteric Transition in the C-Terminal Domain of Calmodulin from Nuclear Magnetic Resonance Measurements
  260. Using Pseudocontact Shifts and Residual Dipolar Couplings as Exact NMR Restraints for the Determination of Protein Structural Ensembles
  261. Parmbsc1: a refined force field for DNA simulations
  262. Structure-Free Validation of Residual Dipolar Coupling and Paramagnetic Relaxation Enhancement Measurements of Disordered Proteins
  263. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function
  264. Mapping the Protein Fold Universe Using the CamTube Force Field in Molecular Dynamics Simulations
  265. The inverted free energy landscape of an intrinsically disordered peptide by simulations and experiments
  266. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
  267. Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity
  268. Targeting disordered proteins with small molecules using entropy
  269. Chromatin Unfolding by Epigenetic Modifications Explained by Dramatic Impairment of Internucleosome Interactions: A Multiscale Computational Study
  270. A Rational Design Strategy for the Selective Activity Enhancement of a Molecular Chaperone toward a Target Substrate
  271. Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
  272. Probing the Residual Structure of the Low Populated Denatured State of ADA2h under Folding Conditions by Relaxation Dispersion Nuclear Magnetic Resonance Spectroscopy
  273. Reply to “Comment on ‘A Tensor-Free Method for the Structural and Dynamic Refinement of Proteins using Residual Dipolar Couplings’”
  274. Dynamic binding mode of a Synaptotagmin-1–SNARE complex in solution
  275. Analysis of the performance of the CHESHIRE and YAPP methods at CASD-NMR round 3
  276. Structure and Dynamics of GeoCyp: A Thermophilic Cyclophilin with a Novel Substrate Binding Mechanism That Functions Efficiently at Low Temperatures
  277. Widespread Proteome Remodeling and Aggregation in Aging C. elegans
  278. Structure and Dynamics of the Integrin LFA-1 I-Domain in the Inactive State Underlie its Inside-Out/Outside-In Signaling and Allosteric Mechanisms
  279. The physical basis of protein misfolding disorders
  280. A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
  281. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
  282. The s2D Method: Simultaneous Sequence-Based Prediction of the Statistical Populations of Ordered and Disordered Regions in Proteins
  283. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases
  284. A Tensor-Free Method for the Structural and Dynamical Refinement of Proteins using Residual Dipolar Couplings
  285. Structure of a low-population intermediate state in the release of an enzyme product
  286. The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
  287. Analysis of the hierarchical structure of the B. subtilis transcriptional regulatory network
  288. The Computational Studies of Co-Translational Protein Folding
  289. Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates
  290. Druggability of Intrinsically Disordered Proteins
  291. Structure and Dynamics of Intrinsically Disordered Proteins
  292. The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
  293. Characterization of the Conformational Fluctuations in the Josephin Domain of Ataxin-3
  294. A Relationship between the Transient Structure in the Monomeric State and the Aggregation Propensities of α-Synuclein and β-Synuclein
  295. ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load
  296. Understanding the frustration arising from the competition between function, misfolding, and aggregation in a globular protein
  297. Identification and characterization of PKCγ, a kinase associated with SCA14, as an amyloidogenic protein
  298. NMR characterization of the conformational fluctuations of the human lymphocyte function‐associated antigen‐1 I‐domain
  299. Equilibrium simulations of proteins using molecular fragment replacement and NMR chemical shifts
  300. Archaeal MBF1 binds to 30S and 70S ribosomes via its helix–turn–helix domain
  301. Cyclophilin A catalyzes proline isomerization by an electrostatic handle mechanism
  302. Statistical Mechanics of the Denatured State of a Protein Using Replica-Averaged Metadynamics
  303. A tensor-free method for the structural and dynamical refinement of proteins using residual dipolar couplings
  304. Flexible anchoring of archaeal MBF1 on ribosomes suggests role as recruitment factor
  305. Erratum: The amyloid state and its association with protein misfolding diseases
  306. Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
  307. The amyloid state and its association with protein misfolding diseases
  308. Understanding the Influence of Codon Translation Rates on Cotranslational Protein Folding
  309. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation
  310. Determination of the Individual Roles of the Linker Residues in the Interdomain Motions of Calmodulin Using NMR Chemical Shifts
  311. ALMOST: An all atom molecular simulation toolkit for protein structure determination
  312. Spatial Propagation of Protein Polymerization
  313. Chemical kinetics for drug discovery to combat protein aggregation diseases
  314. Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
  315. The dynamics of interleukin‐8 and its interaction with human CXC receptor I peptide
  316. A Conformational Ensemble Derived Using NMR Methyl Chemical Shifts Reveals a Mechanical Clamping Transition That Gates the Binding of the HU Protein to DNA
  317. New opportunities for tensor-free calculations of residual dipolar couplings for the study of protein dynamics
  318. A Simple Lattice Model That Captures Protein Folding, Aggregation and Amyloid Formation
  319. Kinetic modelling indicates that fast-translating codons can coordinate cotranslational protein folding by avoiding misfolded intermediates
  320. Structure of a Misfolded Intermediate of a PDZ Domain
  321. Higher Order Amyloid Fibril Structure by MAS NMR and DNP Spectroscopy
  322. A Clear View of Polymorphism, Twist, and Chirality in Amyloid Fibril Formation
  323. Replica-Averaged Metadynamics
  324. Widespread Aggregation and Neurodegenerative Diseases Are Associated with Supersaturated Proteins
  325. pE-DB: a database of structural ensembles of intrinsically disordered and of unfolded proteins
  326. Erratum: “Molecular dynamics simulations with replica-averaged structural restraints generate structural ensembles according to the maximum entropy principle” [J. Chem. Phys. 138, 094112 (2013)]
  327. Subdomain Architecture and Stability of a Giant Repeat Protein
  328. Cucurbit[8]uril and Blue-Box: High-Energy Water Release Overwhelms Electrostatic Interactions
  329. A Relationship between the Aggregation Rates of α-Synuclein Variants and the β-Sheet Populations in Their Monomeric Forms
  330. Characterization of the Interdomain Motions in Hen Lysozyme Using Residual Dipolar Couplings as Replica-Averaged Structural Restraints in Molecular Dynamics Simulations
  331. Structures of the Excited States of Phospholamban and Shifts in Their Populations upon Phosphorylation
  332. In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of α-Synuclein within E. coli Cells
  333. A geometrical parametrization of C1′-C5′ RNA ribose chemical shifts calculated by density functional theory
  334. Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide
  335. Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages
  336. Single-Molecule Measurements of Transient Biomolecular Complexes through Microfluidic Dilution
  337. A method of determining RNA conformational ensembles using structure-based calculations of residual dipolar couplings
  338. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
  339. Integration and characterization of solid wall electrodes in microfluidic devices fabricated in a single photolithography step
  340. The codon information index: a quantitative measure of the information provided by the codon bias
  341. Characterization of the free-energy landscapes of proteins by NMR-guided metadynamics
  342. Atomic structure and hierarchical assembly of a cross-β amyloid fibril
  343. Protein self-assembly intermediates
  344. Molecular dynamics simulations with replica-averaged structural restraints generate structural ensembles according to the maximum entropy principle
  345. Erratum: Prediction of variable translation rate effects on cotranslational protein folding
  346. Analysis of the Contributions of Ring Current and Electric Field Effects to the Chemical Shifts of RNA Bases
  347. Assessment of the Use of NMR Chemical Shifts as Replica-Averaged Structural Restraints in Molecular Dynamics Simulations to Characterize the Dynamics of Proteins
  348. R state structure of monomeric phospholamban (C36A, C41F, C46A)
  349. Sequence-Based Prediction of Protein Behavior
  350. The Kinetics and Mechanisms of Amyloid Formation
  351. Characterization of Free Energy Landscapes of Proteins using NMR Spectroscopy
  352. In Vivo Translation Rates Can Substantially Delay the Co-Translational Folding of the E. Coli Cytosolic Proteome
  353. Thermodynamics of an Intrinsically Disordered Protein by Atomistic Simulations
  354. In vivo translation rates can substantially delay the cotranslational folding of the Escherichia coli cytosolic proteome
  355. A Rationally Designed Six-Residue Swap Generates Comparability in the Aggregation Behavior of α-Synuclein and β-Synuclein
  356. Twisting Transition between Crystalline and Fibrillar Phases of Aggregated Peptides
  357. In support of the BMRB
  358. ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load
  359. From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
  360. Sequence-Based Prediction of Protein Solubility
  361. Trigger Factor Slows Co-translational Folding through Kinetic Trapping while Sterically Protecting the Nascent Chain from Aberrant Cytosolic Interactions
  362. Determination of structural fluctuations of proteins from structure-based calculations of residual dipolar couplings
  363. Protein Structure Validation Using Side-Chain Chemical Shifts
  364. Structure of an Intermediate State in Protein Folding and Aggregation
  365. Proteome folding and aggregation
  366. Fibrillogenic propensity of the GroEL apical domain: A Janus-faced minichaperone
  367. Determination of Secondary Structure Populations in Disordered States of Proteins Using Nuclear Magnetic Resonance Chemical Shifts
  368. Characterization of the Conformational Equilibrium between the Two Major Substates of RNase A Using NMR Chemical Shifts
  369. Blind Testing of Routine, Fully Automated Determination of Protein Structures from NMR Data
  370. Prediction of variable translation rate effects on cotranslational protein folding
  371. Determination of Conformational Equilibria in Proteins Using Residual Dipolar Couplings
  372. Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility
  373. Coarse-grained model for protein folding based on structural profiles
  374. Inversion of the Balance between Hydrophobic and Hydrogen Bonding Interactions in Protein Folding and Aggregation
  375. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism
  376. Metastability of Native Proteins and the Phenomenon of Amyloid Formation
  377. Nucleated Polymerisation in the Presence of Pre-Formed Seed Filaments
  378. Using Side-Chain Aromatic Proton Chemical Shifts for a Quantitative Analysis of Protein Structures
  379. Using Side-Chain Aromatic Proton Chemical Shifts for a Quantitative Analysis of Protein Structures
  380. Excited-State Control of Protein Activity
  381. The A53T Mutation is Key in Defining the Differences in the Aggregation Kinetics of Human and Mouse α-Synuclein
  382. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations
  383. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
  384. Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations
  385. Protein Solubility and Protein Homeostasis: A Generic View of Protein Misfolding Disorders
  386. Using Chemical Shifts to Determine Structural Changes in Proteins upon Complex Formation
  387. Structure-based prediction of methyl chemical shifts in proteins
  388. The statistical theory of allostery
  389. 1H, 13C and 15N resonance assignments of human muscle acylphosphatase
  390. Asymmetric folding pathways and transient misfolding in a coarse-grained model of proteins
  391. Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I
  392. Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease
  393. Faculty Opinions recommendation of A transient and low-populated protein-folding intermediate at atomic resolution.
  394. On the Effect of the Ribosome and Trigger Factor on Nascent Chain Protein Folding
  395. New Scenarios of Protein Folding Can Occur on the Ribosome
  396. The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster
  397. Interactions in the native state of monellin, which play a protective role against aggregation
  398. Protein Dynamics: Moore's Law in Molecular Biology
  399. Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions
  400. Transient Tertiary Structure Formation within the Ribosome Exit Port
  401. Focus on Physical Principles of Protein Behavior in the Cell
  402. Structural characterization of a misfolded intermediate populated during the folding process of a PDZ domain
  403. Translationally optimal codons associate with aggregation-prone sites in proteins
  404. Accurate Determination of Interstrand Distances and Alignment in Amyloid Fibrils by Magic Angle Spinning NMR
  405. Proteome-Level Interplay between Folding and Aggregation Propensities of Proteins
  406. Enzymatic activity in disordered states of proteins
  407. Functional interactions as a survival strategy against abnormal aggregation
  408. Faculty Opinions recommendation of Widespread protein aggregation as an inherent part of aging in C. elegans.
  409. Using NMR Chemical Shifts as Structural Restraints in Molecular Dynamics Simulations of Proteins
  410. Physicochemical Determinants of Chaperone Requirements
  411. Time Averaging of NMR Chemical Shifts in the MLF Peptide in the Solid State
  412. Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
  413. Faculty Opinions recommendation of NMR spectroscopy brings invisible protein states into focus.
  414. Efficient identification of near-native conformations in ab initio protein structure prediction using structural profiles
  415. Derivation of a solubility condition for proteins from an analysis of the competition between folding and aggregation
  416. Determination of the Free Energy Landscape of α-Synuclein Using Spin Label Nuclear Magnetic Resonance Measurements
  417. An Analytical Solution to the Kinetics of Breakable Filament Assembly
  418. Accurate Random Coil Chemical Shifts from an Analysis of Loop Regions in Native States of Proteins
  419. Analysis of Sub-τc and Supra-τc Motions in Protein Gβ1 Using Molecular Dynamics Simulations
  420. Fast and Accurate Predictions of Protein NMR Chemical Shifts from Interatomic Distances
  421. On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of α-Synuclein with Congo Red and Lacmoid
  422. A Condensation-Ordering Mechanism in Nanoparticle-Catalyzed Peptide Aggregation
  423. Factors That Affect the Degree of Twist in β-Sheet Structures: A Molecular Dynamics Simulation Study of a Cross-β Filament of the GNNQQNY Peptide
  424. Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins
  425. Physical Principles of Protein Behavior in the Cell
  426. Folding of Small Proteins by Monte Carlo Simulations with Chemical Shift Restraints without the Use of Molecular Fragment Replacement or Structural Homology
  427. Competition between Intramolecular and Intermolecular Interactions in an Amyloid-Forming Protein
  428. Position-Dependent Electrostatic Protection against Protein Aggregation
  429. A Relationship between mRNA Expression Levels and Protein Solubility in E. coli
  430. Mutational Analysis of the Aggregation-Prone and Disaggregation-Prone Regions of Acylphosphatase
  431. Toward an Accurate Determination of Free Energy Landscapes in Solution States of Proteins
  432. The mechanism of folding of Im7 reveals competition between functional and kinetic evolutionary constraints
  433. Factors That Affect the Degree of Twist in β-Sheet Structures: A Molecular Dynamics Simulation Study of a Cross-β Filament of the GNNQQNY Peptide
  434. Competition between Folding, Native-State Dimerisation and Amyloid Aggregation in β-Lactoglobulin
  435. Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations
  436. Quantitative approaches to defining normal and aberrant protein homeostasis
  437. Networks in Cell Biology
  438. Self-Templated Nucleation in Peptide and Protein Aggregation
  439. Comparison of successive transition states for folding reveals alternative early folding pathways of two homologous proteins
  440. Determination of Protein Structures in the Solid State from NMR Chemical Shifts
  441. Structure Determination of Protein−Protein Complexes Using NMR Chemical Shifts: Case of an Endonuclease Colicin−Immunity Protein Complex
  442. A Generic Mechanism of Emergence of Amyloid Protofilaments from Disordered Oligomeric Aggregates
  443. Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
  444. Introduction to the special issue of GENE
  445. A stochastic method for the reconstruction of protein structures from one-dimensional structural profiles
  446. Competition between protein aggregation and protein complex formation
  447. Structure and Dynamics of a Partially Folded Protein Are Decoupled from Its Mechanism of Aggregation
  448. ChemInform Abstract: The Zyggregator Method for Predicting Protein Aggregation Propensities
  449. Protein dynamics under light control
  450. Characterizing the First Steps of Amyloid Formation for the ccβ Peptide
  451. Prediction by Graph Theoretic Measures of Structural Effects in Proteins Arising from Non-Synonymous Single Nucleotide Polymorphisms
  452. Prediction of Aggregation-Prone Regions in Structured Proteins
  453. Mapping of Two Networks of Residues That Exhibit Structural and Dynamical Changes upon Binding in a PDZ Domain Protein
  454. Biological function in a non-native partially folded state of a protein
  455. A Coupled Equilibrium Shift Mechanism in Calmodulin-Mediated Signal Transduction
  456. Molecular determinants of the aggregation behavior of α- and β-synuclein
  457. Determination of the Transition State Ensemble for the Folding of Ubiquitin from a Combination of Φ and Ψ Analyses
  458. Characterisation of transition state structures for protein folding using 'high', 'medium' and 'low'  -values
  459. Towards quantitative predictions in cell biology using chemical properties of proteins
  460. The Zyggregator method for predicting protein aggregation propensities
  461. Stochastic reconstruction of protein structures from effective connectivity profiles
  462. Calculation of the free energy barriers in the oligomerisation of Ab
  463. Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils
  464. The Distribution of Residues in a Polypeptide Sequence Is a Determinant of Aggregation Optimized by Evolution
  465. Influence of the fluctuations of the alignment tensor on the analysis of the structure and dynamics of proteins using residual dipolar couplings
  466. Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity
  467. Importance of Metastable States in the Free Energy Landscapes of Polypeptide Chains
  468. More charges against aggregation
  469. Characterisation of Amyloid Fibril Formation by Small Heat-shock Chaperone Proteins Human αA-, αB- and R120G αB-Crystallins
  470. Molecular dynamics simulations from putative transition states of α-spectrin SH3 domain
  471. Characterization of the nucleation barriers for protein aggregation and amyloid formation
  472. Protein structure determination from NMR chemical shifts
  473. Similarities in the thermodynamics and kinetics of aggregation of disease-related Aβ(1-40) peptides
  474. Life on the edge: a link between gene expression levels and aggregation rates of human proteins
  475. Determination of conformationally heterogeneous states of proteins
  476. Prediction of Local Structural Stabilities of Proteins from Their Amino Acid Sequences
  477. The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native state ensembles of proteins
  478. A PDZ domain recapitulates a unifying mechanism for protein folding
  479. The Structurally Constrained Neutral Model of Protein Evolution
  480. Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils
  481. BPPred: A Web-based computational tool for predicting biophysical parameters of proteins
  482. Geometry, Energetics, and Dynamics of Hydrogen Bonds in Proteins:  Structural Information Derived from NMR Scalar Couplings
  483. STRUCTURAL BIOLOGY: Dynamic Visions of Enzymatic Reactions
  484. Characterization of the residual structure in the unfolded state of the Δ131Δ fragment of staphylococcal nuclease
  485. Relation between native ensembles and experimental structures of proteins
  486. Structural Comparison of the Two Alternative Transition States for Folding of TI I27
  487. Theoretical Approaches to Protein Aggregation
  488. Structural Interpretation of Hydrogen Exchange Protection Factors in Proteins: Characterization of the Native State Fluctuations of CI2
  489. Determination of an ensemble of structures representing the intermediate state of the bacterial immunity protein Im7
  490. Effective interactions between chaotropic agents and proteins
  491. Transition State Contact Orders Correlate with Protein Folding Rates
  492. Form of Growing Strings
  493. Determination of the folding transition states of barnase by using Φ I -value-restrained simulations validated by double mutant Φ IJ -values
  494. Interpreting Dynamically-Averaged Scalar Couplings in Proteins
  495. Prediction of “Aggregation-prone” and “Aggregation-susceptible” Regions in Proteins Associated with Neurodegenerative Diseases
  496. Comparison of Sequence-Based and Structure-Based Energy Functions for the Reversible Folding of a Peptide
  497. Detection of non-native hydrophobic interactions in the denatured state of lysozyme by molecular dynamics simulations
  498. A glimpse at the organization of the protein universe
  499. Formation of Native and Non-native Interactions in Ensembles of Denatured ACBP Molecules from Paramagnetic Relaxation Enhancement Studies
  500. Looking at structure, stability, and evolution of proteins through the principal eigenvector of contact matrices and hydrophobicity profiles
  501. Towards complete descriptions of the free–energy landscapes of proteins
  502. Simultaneous determination of protein structure and dynamics
  503. Protein folding and the organization of the protein topology universe
  504. Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations
  505. Prediction of Site-Specific Amino Acid Distributions and Limits of Divergent Evolutionary Changes in Protein Sequences
  506. Principal eigenvector of contact matrices and hydrophobicity profiles in proteins
  507. Comparison of the Transition States for Folding of Two Ig-like Proteins from Different Superfamilies
  508. Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains
  509. Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR
  510. Molecular Dynamics Studies of the Process of Amyloid Aggregation of Peptide Fragments of Transthyretin
  511. Determination of Protein Structures Consistent with NMR Order Parameters
  512. Reconstruction of Protein Structures from a Vectorial Representation
  513. Transition states for protein folding have native topologies despite high structural variability
  514. Determination of an Ensemble of Structures Representing the Denatured State of the Bovine Acyl-Coenzyme A Binding Protein
  515. Inhibition of protein crystallization by evolutionary negative design
  516. Comparison of the transition state ensembles for folding of Im7 and Im9 determined using all-atom molecular dynamics simulations with ϕ value restraints
  517. Rare Fluctuations of Native Proteins Sampled by Equilibrium Hydrogen Exchange
  518. Structures and relative free energies of partially folded states of proteins
  519. Statistical Properties of Neutral Evolution
  520. Calculation of Mutational Free Energy Changes in Transition States for Protein Folding
  521. Analysis of the distributed computing approach applied to the folding of a small β peptide
  522. Protein folding and misfolding: a paradigm of self–assembly and regulation in complex biological systems
  523. Connectivity of Neutral Networks, Overdispersion, and Structural Conservation in Protein Evolution
  524. Protein folding: bringing theory and experiment closer together
  525. Self-consistent determination of the transition state for protein folding: Application to a fibronectin type III domain
  526. Validity of Gō Models: Comparison with a Solvent-Shielded Empirical Energy Decomposition
  527. Determination of the structures of distinct transition state ensembles for a β-sheet peptide with parallel folding pathways
  528. Determination of a Transition State at Atomic Resolution from Protein Engineering Data
  529. Lack of Self-Averaging in Neutral Evolution of Proteins
  530. Small-world view of the amino acids that play a key role in protein folding
  531. Native and non-native interactions along protein folding and unfolding pathways
  532. Statistical properties of contact vectors
  533. Automated assignment of SCOP and CATH protein structure classifications from FSSP scores
  534. Energetics of enzyme stability
  535. Three key residues form a critical contact network in a protein folding transition state
  536. How to guarantee optimal stability for most representative structures in the protein data bank
  537. Comparison of two optimization methods to derive energy parameters for protein folding: Perceptron and Z score
  538. Toward an energy function for the contact map representation of proteins
  539. Toward an energy function for the contact map representation of proteins
  540. Structurally constrained protein evolution: results from a lattice simulation
  541. A statistical mechanical method to optimize energy functions for protein folding
  542. Can a pairwise contact potential stabilize native protein folds against decoys obtained by threading?
  543. Protein folding using contact maps
  544. Comparison of two optimization methods to derive energy parameters for protein folding: Perceptron andZ score
  545. Folding Lennard-Jones proteins by a contact potential
  546. Neutral Evolution of Model Proteins: Diffusion in Sequence Space and Overdispersion
  547. Hydrophobicity and unique folding of selected polymers
  548. Protein Folding in Contact Map Space
  549. Statistical properties of contact maps
  550. An optimal derivation of a potential for protein folding
  551. Pairwise contact potentials are unsuitable for protein folding
  552. Efficient dynamics in the space of contact maps
  553. High-Dimensional Bak-Sneppen Model
  554. Protein stability and foldability–designability complementarity
  555. Recovery of protein structure from contact maps
  556. Stability Threshold as a Selection Principle for Protein Design
  557. Growth with memory
  558. Modified configurational bias Monte Carlo method for simulation of polymer systems
  559. Model of correlated evolution
  560. Hot sandpiles
  561. Optimal Protein Design Procedure
  562. Diffusion in disordered media as a process with memory
  563. Disordered flat phase and phase diagram for restricted solid-on-solid models of fcc (110) surfaces
  564. Quenched disorder, memory, and self-organization
  565. Evolution of the missing row deconstruction on Rh (110)
  566. A mean-field study of the temperature dependence of the layer magnetizations in a semi-infinite ising model
  567. Magnetic-Phase Transitions of Ising Surfaces with Modified Surface-Bulk Coupling: a Monte Carlo Study
  568. Network views of the cell
  569. Introduction
  570. Protein folding using inter-residue contact